Long-Term Accumulation, Biological Effects and Toxicity of BSA-Coated Gold Nanoparticles in the Mouse Liver, Spleen, and Kidneys

References

• Dykman LA, Khlebtsov NG. Gold nanoparticles in biology and medicine: recent advances and prospects. Acta Naturae. 2011;3(2):34–55. doi:10.32607/20758251-2011-3-2-34-55
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Y, Liu GK, et al. Recent progress in the applications of gold-based nanoparticles towards tumor-targeted imaging and therapy. RSC Adv. 2022;12(13):7635–7651. doi:10.1039/d2ra00566b
   PubMed Web of Science ®Google Scholar
• Hu X, Zhang Y, Ding T, et al. Multifunctional gold nanoparticles: a novel nanomaterial for various medical applications and biological activities. Front Bioeng Biotechnol. 2020;8. doi:10.3389/fbioe.2020.00990
   Web of Science ®Google Scholar
• Dreaden EC, Alkilany AM, Huang X, et al. The golden age: gold nanoparticles for biomedicine. Chem Soc Rev. 2012;41:2740–2779. doi:10.1039/c1cs15237h
   PubMed Web of Science ®Google Scholar
• Alric C, Taleb J, Le Duc G, et al. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. J Am Chem Soc. 2008;130(18):5908–5915. doi:10.1021/ja078176p
   PubMed Web of Science ®Google Scholar
• Sibuyi NRS, Moabelo KL, Fadaka AO, et al. Multifunctional gold nanoparticles for improved diagnostic and therapeutic applications: a review. Nanoscale Res Lett. 2021;16(1). doi:10.1186/s11671-021-03632-w
   PubMed Web of Science ®Google Scholar
• Arnida, Janát-Amsbury MM, Ray A, Peterson CM, Ghandehari H, Ghandehari H. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm. 2011;77(3):417–423. doi:10.1016/j.ejpb.2010.11.010
   PubMed Web of Science ®Google Scholar
• Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun. 2010;393(4):649–655. doi:10.1016/j.bbrc.2010.02.046
   PubMed Web of Science ®Google Scholar
• Pan Y, Leifert A, Ruau D, et al. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small. 2009;5(18):2067–2076. doi:10.1002/smll.200900466
   PubMed Web of Science ®Google Scholar
• Goodman CM, McCusker CD, Yilmaz T, et al. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjugate Chem. 2004;15(4):897–900. doi:10.1021/bc049951i
   PubMed Web of Science ®Google Scholar
• Sani A, Cao C, Cui D. Toxicity of gold nanoparticles (AuNPs): a review. Biochem Biophys Rep. 2021;26:100991. doi:10.1021/bc049951i
   PubMedGoogle Scholar
• Fraga S, Brandão A, Soares ME, et al. Short- and long-term distribution and toxicity of gold nanoparticles in the rat after a single-dose intravenous administration. Nanomedicine. 2014;10(8):1757–1766. doi:10.1016/j.nano.2014.06.005
   PubMed Web of Science ®Google Scholar
• Abu-Dief AM, Salaheldeen M, El-Dabea T. Recent advances in development of gold nanoparticles for drug delivery systems. J Mod Nanotechnol. 2021;1(1). doi:10.53964/jmn.2021001
   Google Scholar
• Nghiem THL, Nguyen TT, Fort E, et al. Capping and in vivo toxicity studies of gold nanoparticles. Adv Nat Sci. 2012;3(1):015002.
   Google Scholar
• Brewer SH, Glomm WR, Johnson MC, et al. Probing BSA binding to citrate-coated gold nanoparticles and surfaces. Langmuir. 2005;21(20):9303–9307. doi:10.1021/la050588t
   PubMed Web of Science ®Google Scholar
• Zhang XD, Wu D, Shen X, et al. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int j Nanomed. 2011;6:2071–2081. doi:10.2147/IJN.S21657
   PubMed Web of Science ®Google Scholar
• Zhang XD, Wu HY, Wu D, et al. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int j Nanomed. 2010;5:771–781. doi:10.2147/IJN.S8428
   PubMed Web of Science ®Google Scholar
• Kimling J, Maier M, Okenve B, et al. Turkevich method for gold nanoparticle synthesis revisited. J Phys Chem B. 2006;110(32):15700–15707. doi:10.1021/jp061667w
   PubMed Web of Science ®Google Scholar
• Nemethova V, Buliakova B, Mazancova P, et al. Intracellular uptake of magnetite nanoparticles: a focus on physico-chemical characterization and interpretation of in vitro data. Mater Sci Eng. 2017;70:161–168. doi:10.1016/j.msec.2016.08.064
   Google Scholar
• Wu Y, Cao Y, Xu K, et al. Dynamically remodeled hepatic extracellular matrix predicts prognosis of early-stage cirrhosis. Cell Death Dis. 2021;12(2):163. doi:10.1038/s41419-021-03443-y
   PubMed Web of Science ®Google Scholar
• Yang RSH, Chang LW, Wu JP, et al. Persistent tissue kinetics and redistribution of nanoparticles, quantum Dot 705, in Mice: ICP-MS quantitative assessment. Environ Health Perspect. 2007;115(9):1339–1343. doi:10.1289/ehp.10290
   PubMed Web of Science ®Google Scholar
• Lopez-Chaves C, Soto-Alvaredo J, Montes-Bayon M, et al. Gold nanoparticles: distribution, bioaccumulation and toxicity. In vitro and in vivo studies. Nanomedicine. 2018;14(1):1–12. doi:10.1016/j.nano.2017.08.011
   PubMed Web of Science ®Google Scholar
• de Jong WH, Hagens WI, Krystek P, et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials. 2008;29(12):1912–1919. doi:10.1016/j.biomaterials.2007.12.037
   PubMed Web of Science ®Google Scholar
• Aravinthan A, Kamala-Kannan S, Govarthanan M, et al. Accumulation of biosynthesized gold nanoparticles and its impact on various organs of Sprague Dawley rats: a systematic study. Toxicol Res. 2016;5(6):1530–1538. doi:10.1039/c6tx00202a
   Web of Science ®Google Scholar
• Kozics K, Sramkova M, Kopecka K, et al. Pharmacokinetics, Biodistribution, and Biosafety of PEGylated Gold Nanoparticles In Vivo. Nanomaterials. 2021;11(7):1702. doi:10.3390/nano11071702
   Web of Science ®Google Scholar
• Dutta S, Sengupta P. Men and mice: relating their ages. Life Sci. 2016;152:244–248. doi:10.1016/j.lfs.2015.10.025
   PubMed Web of Science ®Google Scholar
• Vines JB, Yoon JH, Ryu NE, et al. Gold nanoparticles for photothermal cancer therapy. Front Chem. 2019;7:167. doi:10.3389/fchem.2019.00167
   PubMed Web of Science ®Google Scholar
• Jain S, Hirst DG, O’Sullivan JM. Gold nanoparticles as novel agents for cancer therapy. Br J Radiol. 2012;85(1010):101–113. doi:10.1259/bjr/59448833
   PubMed Web of Science ®Google Scholar
• Yang Y, Zheng X, Chen L, et al. Multifunctional gold nanoparticles in cancer diagnosis and treatment. Int j Nanomed. 2022;17:2041–2067. doi:10.2147/IJN.S355142
   PubMed Web of Science ®Google Scholar
• Downs TR, Crosby ME, Hu T, et al. Silica nanoparticles administered at the maximum tolerated dose induce genotoxic effects through an inflammatory reaction while gold nanoparticles do not. Mutat Res. 2012;745(1–2):38–50. doi:10.1016/j.mrgentox.2012.03.012
   PubMed Web of Science ®Google Scholar
• Schulz M, Ma-Hock L, Brill S, et al. Investigation on the genotoxicity of different sizes of gold nanoparticles administered to the lungs of rats. Mutat Res. 2012;745(1–2):51–57. doi:10.1016/j.mrgentox.2011.11.016
   PubMed Web of Science ®Google Scholar
• Javed I, Hussain SZ, Shahzad A, et al. Lecithin-gold hybrid nanocarriers as efficient and pH selective vehicles for oral delivery of diacerein-In-vitro and in-vivo study. Colloids Surf B. 2016;141:1–9. doi:10.1016/j.colsurfb.2016.01.022
   PubMed Web of Science ®Google Scholar
• Paino IMM, Marangoni VS, de Oliveira R de CS, et al. Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells. Toxicol Lett. 2012;215(2):119–125. doi:10.1016/j.toxlet.2012.09.025
   PubMed Web of Science ®Google Scholar
• Liu H, Liu T, Wang H, et al. Impact of PEGylation on the biological effects and light heat conversion efficiency of gold nanoshells on silica nanorattles. Biomaterials. 2013;34(28):6967–6975. doi:10.1016/j.biomaterials.2013.05.059
   PubMed Web of Science ®Google Scholar
• Cho WS, Cho M, Jeong J, et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol. 2009;236(1):16–24. doi:10.1016/j.taap.2008.12.023
   PubMed Web of Science ®Google Scholar
• Brzoska K, Szczygiel M, Drzał A, et al. Transient vasodilation in mouse 4T1 tumors after intragastric and intravenous administration of gold nanoparticles. Int J Mol Sci. 2021;22(5):2361. doi:10.3390/ijms22052361
   PubMed Web of Science ®Google Scholar
• Komatsu T, Nakamura K, Okumura Y, Konishi K. Optimal method of gold nanoparticle administration in melanoma-bearing mice. Exp Ther Med. 2018;15(3):2994–2999. doi:10.3892/etm.2018.5746
   PubMed Web of Science ®Google Scholar
• Degli Esposti D, Hamelin J, Bosselut N, et al. Mitochondrial roles and cytoprotection in chronic liver injury. Biochem Res Int. 2012;387626. doi:10.1155/2012/387626
   Google Scholar
• Zhang IW, López-Vicario C, Duran-Güell M, et al. Mitochondrial dysfunction in advanced liver disease: emerging concepts. Front Mol Biosci. 2021;8:772174. doi:10.3389/fmolb.2021.772174
   PubMed Web of Science ®Google Scholar
• Ali MRK, Rahman MA, Wu Y, et al. Efficacy, long-term toxicity, and mechanistic studies of gold nanorods photothermal therapy of cancer in xenograft mice. Proc Natl Acad Sci USA. 2017;114:3110–3118. doi:10.1073/pnas.1619302114
   PubMed Web of Science ®Google Scholar
• Cho WS, Cho M, Jeong J, et al. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol. 2010;245(1):116–123. doi:10.1016/j.taap.2010.02.013
   PubMed Web of Science ®Google Scholar
• Poon W, Zhang YN, Ouyang B, et al. Elimination Pathways of Nanoparticles. ACS Nano. 2019;13(5):5785–5798. doi:10.1021/acsnano.9b01383
   PubMed Web of Science ®Google Scholar
• Melsom T, Stefansson V, Schei J, et al. Association of increasing GFR with change in albuminuria in the general population. Clin J Am Soc Nephrol. 2016;11(12):2186–2194. doi:10.2215/CJN.04940516
   PubMed Web of Science ®Google Scholar
• Babelova A, Avaniadi D, Jung O, et al. Role of Nox4 in murine models of kidney disease. Free Radic Biol Med. 2012;53(4):842–853. doi:10.1016/j.freeradbiomed.2012.06.027
   PubMed Web of Science ®Google Scholar
• Bülow RD, Boor P. Extracellular matrix in kidney fibrosis: more than just a scaffold. J Histochem Cytochem. 2019;67(9):643–661. doi:10.1369/0022155419849388
   PubMed Web of Science ®Google Scholar
• Norris KC, Smoyer KE, Rolland C, et al. Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review. BMC Nephrol. 2018;19(1):36. doi:10.1186/s12882-018-0821-9
   PubMed Web of Science ®Google Scholar
• Elwan WM, Ragab AMH, Ragab MH. Histological and immunohistochemical evaluation of the dose-dependent effect of gold nanoparticles on the renal cortex of adult female albino rat. Egypt J Histol. 2018;41(2):167–181. doi:10.21608/EJH.2018.13839
   Google Scholar
• Hall CL, Tighe R. The effect of continuing penicillamine and gold treatment on the course of penicillamine and gold nephropathy. Br J Rheumatol. 1989;28(1):53–57. doi:10.1093/rheumatology/28.1.53
   PubMedGoogle Scholar
• Robbins G, McIllmurray MB. Acute renal failure due to gold. Postgrad Med J. 1980;56(655):366–367. doi:10.1136/pgmj.56.655.366
   PubMed Web of Science ®Google Scholar
• Antonovych TT. Gold Nephropathy. Ann Clin Lab Sci. 1981;11(5):386–391.
   PubMed Web of Science ®Google Scholar
• Derot M, Kahn J, Mazalton A, et al. Fatal acute anuric nephritis after gold therapy, with associated chrysocyanosis. Bulletins Et Memoires de la Societe Medicale Des Hopitaux de Paris. 1954;70(7–8):234–239.
   PubMedGoogle Scholar